Search Results - "Espin, Frank G."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A Screening Test for HLA-B ∗ 15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events

    A Screening Test for HLA-B ∗ 15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events by Fang, Hua, Xu, Xiequn, Kaur, Kulvinder, Dedek, Matthew, Zhu, Guang-Dan, Riley, Bae J, Espin, Frank G, Del Tredici, Andria L, Moreno, Tanya A

    Published in Frontiers in pharmacology (26-03-2019)
    “…is strongly associated with life-threatening severe skin hypersensitivity reactions in patients treated with carbamazepine (CBZ) and structurally related…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Ambiguous pharmacogenetic genotyping results in a patient with bone marrow transplantation

    Ambiguous pharmacogenetic genotyping results in a patient with bone marrow transplantation by Espin, Frank G., Dedek, Matthew, Moreno, Tanya A., Del Tredici, Andria L., Voland, Joseph R.

    Published in Journal of laboratory medicine (25-10-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Genotypes at rs2844682 and rs3909184 have no clinical value in identifying HLA-B15:02 carriers

    Genotypes at rs2844682 and rs3909184 have no clinical value in identifying HLA-B15:02 carriers by Zhu, Guang-dan, Brenton, Ashley A., Malhotra, Alka, Riley, Bae J., Church, Katherine E., Espin, Frank G., Moreno, Tanya A., Strickland, Jennifer M., Del Tredici, Andria L.

    Published in European journal of clinical pharmacology (01-08-2015)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: